BCM
AMPH icon

Boone Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Boone Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-316,556
Closed -$15.4M – 14
2024
Q3 		$15.4M Sell
316,556
-178,533
-36% -$7.83M 3.98% 13
2024
Q2 		$19.8M Sell
495,089
-111,599
-18% -$4.62M 5.17% 8
2024
Q1 		$26.6M Buy
606,688
+206,688
+52% +$10.7M 5.39% 8
2023
Q4 		$24.7M Buy
+400,000
New +$21M 5.77% 8

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Boone Capital Management's AMPH Position: Q4 2024 in Review

Boone Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2024, closing a stake of 316,556 shares — an estimated $15.4M sold.

Boone Capital Management first reported a position in AMPH in Q4 2023 and held it in 4 quarters. The position peaked at $26.6M in Q1 2024. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

  • Boone Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Boone Capital Management sold 316,556 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $15.4M.
  • Boone Capital Management first reported a position in Amphastar Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Boone Capital Management's Amphastar Pharmaceuticals position peaked at $26.6M in Q1 2024.
  • 263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on Boone Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.